VDC vs XBI
Vanguard Consumer Staples ETF vs SPDR S&P Biotech ETF
- • VDC has the lower expense ratio at 0.09% vs 0.35% for XBI.
- • VDC pays a higher dividend yield (2.02%).
Side-by-side metrics
| Metric | VDC | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.02% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $9.56B | $10.92B |
YTD return | 19.30% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.40 | 1.01 |
P/E ratio | 27.66 | — |
Last price | $247.27 | $156.41 |
Inception | — | — |
Issuer | Vanguard | State Street |
VDC top holdings
| WMT | Walmart Inc | 13.86% |
| COST | Costco Wholesale Corp | 12.12% |
| PG | Procter & Gamble Co | 9.90% |
| KO | Coca-Cola Co | 9.80% |
| PM | Philip Morris International Inc | 4.83% |
| PEP | PepsiCo Inc | 4.28% |
| MO | Altria Group Inc | 3.86% |
| MDLZ | Mondelez International Inc Class A | 2.58% |
| TGT | Target Corp | 2.50% |
| CL | Colgate-Palmolive Co | 2.28% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About VDC
VDC (Vanguard Consumer Staples ETF) is US consumer staples sector stocks. Managed by Vanguard, the fund carries $9.6B in assets under management, an expense ratio of 0.09%, a dividend yield of 2.02%. Its largest holding is Walmart Inc (WMT), which represents 13.9% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 1.4%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.